Matthew Bardin
Director Técnico/Científico/I+D en Romark, L.C. .
Perfil
Matthew Bardin is currently the VP-Medical Affairs, Research & Development at Romark, L.C.
Prior to this, he was the Senior Vice President-Operations at NeuroBo Pharmaceuticals, Inc. from 2022 to 2023.
He holds a doctorate degree from Mcwhorter School of Pharmacy.
Cargos activos de Matthew Bardin
| Empresas | Cargo | Inicio |
|---|---|---|
Romark, L.C.
 Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Director Técnico/Científico/I+D | 06/05/2022 |
Antiguos cargos conocidos de Matthew Bardin.
| Empresas | Cargo | Fin |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Director de Operaciones | 01/02/2023 |
Formación de Matthew Bardin.
| Mcwhorter School of Pharmacy | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Bardin
